A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Last updated: November 1, 2016
Sponsor: Hoffmann-La Roche
Overall Status: Completed

Phase

3

Condition

Kidney Transplantation

Treatment

N/A

Clinical Study ID

NCT00048152
M67005
  • Ages > 18
  • All Genders

Study Summary

This study will compare kidney function in kidney transplant patients following treatment with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine). The anticipated time on study treatment is 6-12 months, and the target sample size is 500+ individuals.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • adult patients greater than 18 years of age

  • recipients of primary kidney transplant

  • single-organ recipients (kidney only)

Exclusion

Exclusion Criteria:

  • previous treatment with Zenapax

  • history of malignancy (except localized skin cancer)

Study Design

Total Participants: 539
Study Start date:
December 01, 2000
Estimated Completion Date:
March 31, 2006

Connect with a study center

  • Adelaide, 5011
    Australia

    Site Not Available

  • Sydney, 2050
    Australia

    Site Not Available

  • Bruxelles, 1070
    Belgium

    Site Not Available

  • Leuven, 3000
    Belgium

    Site Not Available

  • Calgary, Alberta T2N 2T9
    Canada

    Site Not Available

  • Edmonton, Alberta T6G 2R8
    Canada

    Site Not Available

  • Vancouver, British Columbia V6Z 1Y6
    Canada

    Site Not Available

  • Saskatoon, Saskatchewan S7N 0W8
    Canada

    Site Not Available

  • Vandoeuvre-les-nancy, 54511
    France

    Site Not Available

  • Berlin, 13353
    Germany

    Site Not Available

  • Hannover, 30625
    Germany

    Site Not Available

  • Muenster, 48149
    Germany

    Site Not Available

  • Mexico City, 06720
    Mexico

    Site Not Available

  • Monterrey, 06720
    Mexico

    Site Not Available

  • Oslo, 0027
    Norway

    Site Not Available

  • Warszawa, 02-006
    Poland

    Site Not Available

  • Wroclaw, 50-417
    Poland

    Site Not Available

  • Barcelona, 08907
    Spain

    Site Not Available

  • empty

    Córdoba, 14004
    Spain

    Site Not Available

  • Córdoba, 14004
    Spain

    Site Not Available

  • Malaga, 29010
    Spain

    Site Not Available

  • Santander, 39008
    Spain

    Site Not Available

  • Valencia, 46009
    Spain

    Site Not Available

  • Goeteborg, 41345
    Sweden

    Site Not Available

  • Malmoe, 20502
    Sweden

    Site Not Available

  • Birmingham, B15 2TH
    United Kingdom

    Site Not Available

  • Glasgow, G11 6NT
    United Kingdom

    Site Not Available

  • Leicester, LE5 4PW
    United Kingdom

    Site Not Available

  • Birmingham, Alabama 35294
    United States

    Site Not Available

  • San Francisco, California 94143
    United States

    Site Not Available

  • Gainesville, Florida 32610
    United States

    Site Not Available

  • Atlanta, Georgia 30322
    United States

    Site Not Available

  • Livingston, New Jersey 07039
    United States

    Site Not Available

  • Philadelphia, Pennsylvania 19102-1192
    United States

    Site Not Available

  • Charleston, South Carolina 29425-0777
    United States

    Site Not Available

  • Falls Church, Virginia 22042-3300
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.